Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingrid Caras

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Immunological Methods|August 29, 2006
Confirming human antibody responses to a therapeutic monoclonal antibody using a statistical approachLauri Neyer, Jordan Hiller, Kurt Gish, et al.
Stem Cells Translational Medicine|July 3, 2015
Proceedings: Moving Toward Cell-Based Therapies for Heart DiseaseLila R Collins, Catherine Priest, Ingrid Caras, et al.
The Journal of Experimental Medicine|September 10, 2003
Matrilysin-dependent elastolysis by human macrophagesSergey Filippov, Ingrid Caras, Richard Murray, et al.
Journal of Experimental Therapeutics & Oncology|October 10, 2006
Preclinical evaluation of an anti-alpha5beta1 integrin antibody as a novel anti-angiogenic agentVanitha Ramakrishnan, Vinay Bhaskar, Debbie A Law, et al.
Blood|October 2, 2007
Anti-CS1 humanized monoclonal antibody HuLuc63 inhibits myeloma cell adhesion and induces antibody-dependent cellular cytotoxicity in the bone marrow milieuYu-Tzu Tai, Myles Dillon, Weihua Song, et al.
Oncogene|September 5, 2003
Expression of the zinc transporter ZnT4 is decreased in the progression from early prostate disease to invasive prostate cancerSusan M Henshall, Daniel E H Afar, Krishan K Rasiah, et al.
Molecular Cancer Therapeutics|August 10, 2004
Preclinical validation of anti-TMEFF2-auristatin E-conjugated antibodies in the treatment of prostate cancerDaniel E H Afar, Vinay Bhaskar, Eric Ibsen, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Immunological Methods|August 29, 2006
Confirming human antibody responses to a therapeutic monoclonal antibody using a statistical approachLauri Neyer, Jordan Hiller, Kurt Gish, et al.
Stem Cells Translational Medicine|July 3, 2015
Proceedings: Moving Toward Cell-Based Therapies for Heart DiseaseLila R Collins, Catherine Priest, Ingrid Caras, et al.
The Journal of Experimental Medicine|September 10, 2003
Matrilysin-dependent elastolysis by human macrophagesSergey Filippov, Ingrid Caras, Richard Murray, et al.
Journal of Experimental Therapeutics & Oncology|October 10, 2006
Preclinical evaluation of an anti-alpha5beta1 integrin antibody as a novel anti-angiogenic agentVanitha Ramakrishnan, Vinay Bhaskar, Debbie A Law, et al.
Blood|October 2, 2007
Anti-CS1 humanized monoclonal antibody HuLuc63 inhibits myeloma cell adhesion and induces antibody-dependent cellular cytotoxicity in the bone marrow milieuYu-Tzu Tai, Myles Dillon, Weihua Song, et al.
Oncogene|September 5, 2003
Expression of the zinc transporter ZnT4 is decreased in the progression from early prostate disease to invasive prostate cancerSusan M Henshall, Daniel E H Afar, Krishan K Rasiah, et al.
Molecular Cancer Therapeutics|August 10, 2004
Preclinical validation of anti-TMEFF2-auristatin E-conjugated antibodies in the treatment of prostate cancerDaniel E H Afar, Vinay Bhaskar, Eric Ibsen, et al.
Pageof 1